Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Thaddeus R. Tolleson"'
Autor:
Gaurav Aggarwala, Pradeep K. Nair, Eric J. Dippel, Thaddeus R. Tolleson, Christopher LeCroy, Muhammad Attique Khan, Frank Bunch, Elias Kassab, Craig M. Walker, John Miles Mcclure
Publikováno v:
Catheterization and Cardiovascular Interventions
Objective The objective of this study was to investigate the safety and feasibility of treating infrapopliteal lesions using a novel drug delivery catheter locally delivering liquid paclitaxel. Background Balloon angioplasty is currently the Gold Sta
Autor:
Maria Parke, Te Hsin Lung, Gregg W. Stone, James W. Choi, Brent T. McLaurin, Elvin Kedhi, Alexandre Abizaid, David E. Kandzari, Ronald P. Caputo, Roxana Mehran, Stephan Windecker, Azfar Zaman, Azeem Latib, Mihir Kanitkar, Ajay J. Kirtane, Stephen G. Worthley, Matthew J. Price, Tamim Nazif, Douglas Spriggs, Thaddeus R. Tolleson, Timothy Smith, Daniel I. Simon, Srinivasa Potluri, Lilian C. Lee
Publikováno v:
Circulation. Cardiovascular Interventions
Supplemental Digital Content is available in the text.
Background: Despite treatment guidance endorsing shortened dual antiplatelet therapy (DAPT) duration in high bleeding risk (HBR) patients after drug-eluting stents, limited evidence exists t
Background: Despite treatment guidance endorsing shortened dual antiplatelet therapy (DAPT) duration in high bleeding risk (HBR) patients after drug-eluting stents, limited evidence exists t
Autor:
Donald E. Cutlip, Thaddeus R. Tolleson, Resolute Us Investigators, Martin B. Leon, Alan C. Yeung, Joseph M. Massaro, Brent T. Mc Laurin, Ash Jain, Laura Mauri, Jeffrey J. Popma, Peter J. Fitzgerald, Douglas Spriggs
Publikováno v:
Journal of the American College of Cardiology. 57:1778-1783
Objectives The RESOLUTE US (R-US) trial is a prospective, observational study designed to evaluate the clinical effectiveness of the Resolute zotarolimus-eluting stent (R-ZES) in a U.S. population. Background The R-ZES releases zotarolimus over a 6-m
Autor:
Ajay J. Kirtane, Thaddeus R. Tolleson, Eugenia Nikolsky, Ronald P. Caputo, Laura Mauri, Kweli P. Thompson, Bernard Reen, Ash Jain, Martin B. Leon, John S. Douglas, Endeavor Iv Investigators, David E. Kandzari, Stuart L. Solomon, Brent T. McLaurin, Michael W. Ball, Charles O'Shaughnessy, Jeffrey J. Popma, Peter J. Fitzgerald, Paul Overlie, Donald E. Cutlip
Publikováno v:
Journal of the American College of Cardiology. 55:543-554
Objectives: The ENDEAVOR IV (Randomized Comparison of Zotarolimus-Eluting and Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease) trial evaluated the safety and efficacy of the zota...
Autor:
Thaddeus R. Tolleson, Kathryn A Williams, Robert A. Harrington, J.Conor O’Shea, Glenn N. Levine, James E. Tcheng, William B. Hillegass, John A. Bittl
Publikováno v:
Journal of the American College of Cardiology. 41(3):386-393
OBJECTIVES We evaluated the relationship between the degree of heparin anticoagulation and clinical efficacy and bleeding in patients undergoing contemporary percutaneous coronary intervention (PCI) with stent implantation. BACKGROUND Despite univers
Autor:
Peter M. DiBattiste, Robert A. Harrington, Rhonda L. Larsen, Daowen Zhang, Warren J. Cantor, Patricia M. Dillard, James E. Tcheng, E. Magnus Ohman, Robert M. Califf, Yao Huang, R. Michael Mantell, Michael H. Sketch, Wayne Batchelor, Thaddeus R. Tolleson, Daniel D. Gretler, Marie Davidian, James P. Zidar
Publikováno v:
Circulation. 106:1470-1476
Background— The relative anti-aggregatory effects of currently prescribed platelet glycoprotein IIb/IIIa receptor antagonists during and after percutaneous coronary intervention for acute coronary syndromes have not been established. Methods and Re
Autor:
J.Conor O’Shea, M.Cecilia Bahit, Thaddeus R. Tolleson, Christopher Cabell, Christopher K. Dyke, Aditya Kaul, Darren K. McGuire, Mark A. East
Publikováno v:
American Heart Journal. 141:306-318
Autor:
James J. Crowley, James P. Zidar, Fernando A. de la Serna, Thaddeus R. Tolleson, Richard S. Stack
Publikováno v:
Catheterization and Cardiovascular Interventions. 53:264-268
A 33-year-old woman with subacute thrombosis of the distal aorta after aorto-bi-iliac stenting had local thrombolysis with reteplase in conjunction with systemic abciximab. The infusion was given as a bolus and then continuously for 14 hr by radial a
Autor:
J.Conor O’Shea, David E. Kandzari, Mark A. East, Christopher K. Dyke, Thaddeus R. Tolleson, Darren K. McGuire
Publikováno v:
American Heart Journal. 140:181-188
Autor:
Alan C, Yeung, Martin B, Leon, Ash, Jain, Thaddeus R, Tolleson, Douglas J, Spriggs, Brent T, Mc Laurin, Jeffrey J, Popma, Peter J, Fitzgerald, Donald E, Cutlip, Joseph M, Massaro, Laura, Mauri
Publikováno v:
Journal of the American College of Cardiology. 57(17)
The RESOLUTE US (R-US) trial is a prospective, observational study designed to evaluate the clinical effectiveness of the Resolute zotarolimus-eluting stent (R-ZES) in a U.S. population.The R-ZES releases zotarolimus over a 6-month period in order to